返回 Agenda
DIA Startup Accelerator
Session Chair(s)
Falk Ehmann, MD, PHD, MS
Head of Innovation and Development Accelerator
Regulatory Science and Innovation Task Force, European Medicines Agency, Netherlands
Hubert Leufkens, PHARMD, PHD
Emeritus Professor of Pharmaceutical Policy and Regulatory Science
Utrecht University, Netherlands
Rabia Sucu
Senior Technical Advisor
Management Sciences for Health, Ukraine
This session gives innovators the opportunity to learn about pathways to communicate effectively with Regulatory Authorities and HTA bodies and discuss challenges of value and access specific for innovative healthcare products. See real-life examples what happens when HTA and regulatory considerations are tackled later in product development cycle, how those affect market authorization and product acquisition. Create long-lasting relationships with experts who will be able to advise and support you.
13:50 - 14:00: Introduction & Welcome
14:10 - 14:20: The Power of Regulatory and HTA Awareness in the Life of a Startup – my Story
14:20 - 14:30: Introduction to HTA Fundamentals
14:30 - 14:40: Introduction to Regulatory Affairs Opportunities
14:40 - 14:50: Break
14:50 - 15:10: Panel Discussion with Q&A
Speaker(s)
The Power of Regulatory and HTA Awareness in the Life of a Startup – My Story
Thomas Broeckhoff, MSC
hollandbio, Netherlands
Project Manager
Introduction to HTA Fundamentals
Rabia Sucu
Management Sciences for Health, Ukraine
Senior Technical Advisor
Introduction to Regulatory Affairs Opportunities
Falk Ehmann, MD, PHD, MS
Regulatory Science and Innovation Task Force, European Medicines Agency, Netherlands
Head of Innovation and Development Accelerator
Meelis Lootus, PHD, MS, MSC
Tehistark, United Kingdom
Founder & CEO